Overcome side identification in PPOP by making orifices on both layers

International Journal of Pharmaceutics

Volumn 371, Issue 1-2, 2009, Pages 1-7

  Zhang, Zhi hong ^a   Li, Wei ^a,b   Nie, Shu fang ^a   Tang, Xin ^a   Peng, Bo ^a   Tian, Lei ^a   Pan, Wei san ^c  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b AustarPharma LLC   (United States)

^c NONE

Author keywords

Color Identification; Dipyridamole; Gliclazide; Indapamide; Orifice; Push pull osmotic pump (PPOP)

Indexed keywords

DIPYRIDAMOLE; GLICLAZIDE; INDAPAMIDE; NIFEDIPINE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RELEASE; IN VITRO STUDY; OSMOTIC PUMP; PRIORITY JOURNAL;

DIPYRIDAMOLE; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; GLICLAZIDE; HUMANS; INDAPAMIDE; MEMBRANES, ARTIFICIAL; MODELS, THEORETICAL; OSMOSIS; SOLUBILITY; TABLETS, ENTERIC-COATED;

EID: 62749095927     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.12.006     Document Type: Article

References (16)

1. Benkorah A.Y., and Mcmullen J.N. Biconcave coated centrally perforated tablets for oral controlled drug delivery. J. Control. Release 32 (1994) 155-160
2. Cortese, R., Barclay, B., Theeuwes, F., 1984. Simultaneous delivery of two drugs from unit delivery device. US Patent 4,449,983, 22 May.
3. Hansson A.G., Giardino A., Cardinal J., and Curatolo W. Perforated coated tablets for controlled release of drugs at a constant rate. J. Pharm. Sci. 77 (1988) 322-324
4. Liu L., Khang G., Rhee J.M., and Lee H.B. Monolithic osmotic tablet system for nifedipine delivery. J. Control. Release 67 (2000) 309-322
5. Lu E.X., Jiang Z.Q., Zhang Q.Z., and Jiang X.G. Preparation of controlled release coated tablets of naproxen sodium. Chin. Pharm. J. 37 (2002) 841-844
6. Lu E.X., Jiang Z.Q., Zhang Q.Z., and Jiang X.G. A water-insoluble drug monolithic osmotic tablet system utilizing gum Arabic as an osmotic, suspending expanding agent. J. Control. Release 92 (2003) 375-382
7. Ouyang D.F., Nie S.F., Li W., Guo H., Liu H., and Pan W.S. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Dev. Ind. Pharm. 31 (2005) 677-685
8. Okimoto K., Rajewski R.A., and Stella V.J. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-β-CD as both a solubilizing and an osmotic pump agent. J. Control. Release 58 (1999) 29-38
9. Okimoto K., Tokunaga Y., Ibuki R., Irie T., Uekama K., Rajewski R.A., and Stella V.J. Applicability of (SBE) 7m-β-CD in controlled-porosity osmotic pump tablets (OPTs). Int. J. Pharm. 286 (2004) 81-88
10. Shah V.P., Tsong Y., Sathe P., and Liu J. In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2. Pharm. Res. 15 (1998) 889-896
11. Thombre A.G., Appel L.E., Chidlaw M.B., Daugherity P.D., Dumont F., Evans L.A.F., and Sutton S.C. Osmotic drug delivery using swellable-core technology. J. Control. Release 94 (2004) 75-89
12. Theeuwes, F., Higuchi, T., 1972. Osmotic dispensing device for releasing beneficial agent. US Patent 3,845,770, 5 Jun.
13. Theeuwes F. Elementary osmotic pump. J. Pharm. Sci. 64 (1975) 1987-1991
14. Theeuwes, F., 1978. Osmotic system for delivering selected beneficial agents having varying degrees of solubility. US Patent 4,111,201, 5 Sep.
15. Verma R.K., Mishra B., and Garg S. Osmotically controlled oral drug delivery. Drug Dev. Ind. Pharm. 26 (2000) 695-708
16. Verma R.K., Krishna D.M., and Garg S. Formulation aspect in the development of osmotically controlled oral drug delivery systems. J. Control. Release 79 (2002) 7-27